Lithium Clinical Trials Lithium RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

PB to Treat Hereditary Nephrogenic Diabetes Insipidus, ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration
Conditions:   Autosomal Dominant Polycystic Kidney Disease;   Nephrogenic Diabetes Insipidus;   Acquired Nephrogenic Diabetes Insipidus;   Congenital Nephrogenic Diabetes Insipidus Intervention:   Drug: PB Sponsors:   Mayo Clinic;   Hopital du Sacre-Coeur de Montreal Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2022 Category: Research Source Type: clinical trials